Pacira Pharmaceuticals's total assets for Q1 2026 were $1.21B, a decrease of -4.46% from the previous quarter. PCRX total liabilities were $554.64M for the fiscal quarter, a -3.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.